Cargando…

Psychiatric Co-Morbidities in Pregnant Women with Opioid Use Disorders: Prevalence, Impact, and Implications for Treatment

PURPOSE OF REVIEW: This review seeks to investigate three questions: What is the prevalence of comorbid psychiatric diagnoses among pregnant women with opioid use disorder (OUD)? How do comorbid psychiatric illnesses impact pregnant women with OUD? And how do comorbid psychiatric illnesses affect th...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnaudo, Camila L., Andraka-Christou, Barbara, Allgood, Kacy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350195/
https://www.ncbi.nlm.nih.gov/pubmed/28357191
http://dx.doi.org/10.1007/s40429-017-0132-4
_version_ 1782514612311162880
author Arnaudo, Camila L.
Andraka-Christou, Barbara
Allgood, Kacy
author_facet Arnaudo, Camila L.
Andraka-Christou, Barbara
Allgood, Kacy
author_sort Arnaudo, Camila L.
collection PubMed
description PURPOSE OF REVIEW: This review seeks to investigate three questions: What is the prevalence of comorbid psychiatric diagnoses among pregnant women with opioid use disorder (OUD)? How do comorbid psychiatric illnesses impact pregnant women with OUD? And how do comorbid psychiatric illnesses affect the ability of pregnant women with OUD to adhere to and complete OUD treatment? RECENT FINDINGS: Based on this literature review, 25–33% of pregnant women with OUD have a psychiatric comorbidity, with depression and anxiety being especially common. However, of the 17 studies reviewed only 5 have prevalence rates of dual diagnosis in pregnant women with OUD as their primary outcome measures, their N’s were typically small, methods for determining psychiatric diagnosis were variable, and many of the studies were undertaken with women presenting for treatment which carries with its implicit selection bias. Of the women enrolled in treatment programs for SUD, those with psychiatric comorbidity were more likely to have impaired psychological and family/social functioning than those without psychiatric comorbidity. Greater severity of comorbid psychiatric illness appears to predict poorer adherence to treatment, but more research is needed to clarify this relationship with the psychiatric illness is less severe. SUMMARY: While cooccurrence of psychiatric disorders in pregnant women with opioid use disorder appears to be common, large population-based studies with validated diagnostic tools and longitudinal assessments are needed to obtain definitive rates and characteristics of cooccurring illnesses. Integrated prenatal, addiction, and psychiatric treatment in a setting that provides social support to pregnant patients with OUD is most effective in maintaining women in treatment. More research is still needed to identify optimal treatment settings, therapy modalities, and medication management for dually diagnosed pregnant women with OUD.
format Online
Article
Text
id pubmed-5350195
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-53501952017-03-27 Psychiatric Co-Morbidities in Pregnant Women with Opioid Use Disorders: Prevalence, Impact, and Implications for Treatment Arnaudo, Camila L. Andraka-Christou, Barbara Allgood, Kacy Curr Addict Rep Dual Diagnosis (A Chambers, Section Editor) PURPOSE OF REVIEW: This review seeks to investigate three questions: What is the prevalence of comorbid psychiatric diagnoses among pregnant women with opioid use disorder (OUD)? How do comorbid psychiatric illnesses impact pregnant women with OUD? And how do comorbid psychiatric illnesses affect the ability of pregnant women with OUD to adhere to and complete OUD treatment? RECENT FINDINGS: Based on this literature review, 25–33% of pregnant women with OUD have a psychiatric comorbidity, with depression and anxiety being especially common. However, of the 17 studies reviewed only 5 have prevalence rates of dual diagnosis in pregnant women with OUD as their primary outcome measures, their N’s were typically small, methods for determining psychiatric diagnosis were variable, and many of the studies were undertaken with women presenting for treatment which carries with its implicit selection bias. Of the women enrolled in treatment programs for SUD, those with psychiatric comorbidity were more likely to have impaired psychological and family/social functioning than those without psychiatric comorbidity. Greater severity of comorbid psychiatric illness appears to predict poorer adherence to treatment, but more research is needed to clarify this relationship with the psychiatric illness is less severe. SUMMARY: While cooccurrence of psychiatric disorders in pregnant women with opioid use disorder appears to be common, large population-based studies with validated diagnostic tools and longitudinal assessments are needed to obtain definitive rates and characteristics of cooccurring illnesses. Integrated prenatal, addiction, and psychiatric treatment in a setting that provides social support to pregnant patients with OUD is most effective in maintaining women in treatment. More research is still needed to identify optimal treatment settings, therapy modalities, and medication management for dually diagnosed pregnant women with OUD. Springer International Publishing 2017-03-09 2017 /pmc/articles/PMC5350195/ /pubmed/28357191 http://dx.doi.org/10.1007/s40429-017-0132-4 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Dual Diagnosis (A Chambers, Section Editor)
Arnaudo, Camila L.
Andraka-Christou, Barbara
Allgood, Kacy
Psychiatric Co-Morbidities in Pregnant Women with Opioid Use Disorders: Prevalence, Impact, and Implications for Treatment
title Psychiatric Co-Morbidities in Pregnant Women with Opioid Use Disorders: Prevalence, Impact, and Implications for Treatment
title_full Psychiatric Co-Morbidities in Pregnant Women with Opioid Use Disorders: Prevalence, Impact, and Implications for Treatment
title_fullStr Psychiatric Co-Morbidities in Pregnant Women with Opioid Use Disorders: Prevalence, Impact, and Implications for Treatment
title_full_unstemmed Psychiatric Co-Morbidities in Pregnant Women with Opioid Use Disorders: Prevalence, Impact, and Implications for Treatment
title_short Psychiatric Co-Morbidities in Pregnant Women with Opioid Use Disorders: Prevalence, Impact, and Implications for Treatment
title_sort psychiatric co-morbidities in pregnant women with opioid use disorders: prevalence, impact, and implications for treatment
topic Dual Diagnosis (A Chambers, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350195/
https://www.ncbi.nlm.nih.gov/pubmed/28357191
http://dx.doi.org/10.1007/s40429-017-0132-4
work_keys_str_mv AT arnaudocamilal psychiatriccomorbiditiesinpregnantwomenwithopioidusedisordersprevalenceimpactandimplicationsfortreatment
AT andrakachristoubarbara psychiatriccomorbiditiesinpregnantwomenwithopioidusedisordersprevalenceimpactandimplicationsfortreatment
AT allgoodkacy psychiatriccomorbiditiesinpregnantwomenwithopioidusedisordersprevalenceimpactandimplicationsfortreatment